Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,478.00
-31.70 (-2.10%)
Sep 26, 2025, 9:30 AM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1.22 trillion as of September 25, 2025. Its market cap has decreased by -6.79% in one year.
Market Cap
1.22T
Enterprise Value
1.12T
Revenue
274.80B
Ranking
n/a
PE Ratio
22.62
Stock Price
1,478.00
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.22T, an increase of 80,461.84%. That is a compound annual growth rate of 25.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2025 | 1,219.47B | -1.25% |
| Dec 31, 2024 | 1,234.84B | 22.72% |
| Dec 29, 2023 | 1,006.20B | 15.87% |
| Dec 30, 2022 | 868.37B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | 661.25B | 71.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,903.96B |
| Divi's Laboratories | 1,588.56B |
| Apollo Hospitals Enterprise | 1,096.21B |
| Mankind Pharma | 1,042.71B |
| Zydus Lifesciences | 1,025.60B |
| Fortis Healthcare | 713.13B |
| Alkem Laboratories | 666.69B |
| Aurobindo Pharma | 637.14B |